Comparison of Gastric Bypass and Sleeve Gastrectomy in Metabolic and Cardiovascular Indices
- Conditions
- Morbid Obesity
- Registration Number
- NCT03851874
- Lead Sponsor
- National and Kapodistrian University of Athens
- Brief Summary
- Morbidly obese patients undergoing either Roux en Y gastric bypass or sleeve gastrectomy were examined preoperatively, 3, 6, and 12 months after surgery. On each occasion, anthropometric data were collected, resting metabolic rate was measured, and the patients underwent a panel of cardiovascular examinations (heart rate variability, baroreflex sensitivity, heart ultrasound). Following that, they consumed a test meal and completed visual analog scales for the subjective assessment of hunger and fullness every 30 minutes for 3 hours. At the same time points, blood samples were collected for the consequent measurement of glucose, insulin, lipids, and gastrointestinal hormones. 
- Detailed Description
- Not available 
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 28
- BMI >40 kg/m2
- Age between 18 and 65 years
- Proven failure to lose weight through non-surgical interventions
- Serious and life threatening comorbidities (renal, cardiac, liver failure, or malignancy)
- Patients' inability to adhere to postsurgical instructions
- Alcohol or other substance abuse
- Concurrent psychiatric illness
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
- Name - Time - Method - Change in postprandial ghrelin responses - 3, 6, and 12 months - Change in the cumulative postprandial response for ghrelin - Change in postprandial GLP-1 responses - 3, 6, and 12 months - Change in the cumulative postprandial response for GLP-1 - Change in postprandial PYY responses - 3, 6, and 12 months - Change in the cumulative postprandial response for PYY 
- Secondary Outcome Measures
- Name - Time - Method - Change in weight - 3, 6, and 12 months - Change in weight (percentage of weight lost through each procedure) - Change in postprandial glycemia - 3, 6, and 12 months - Change in the cumulative postprandial response for glucose - Change in postprandial insulinemia - 3, 6, and 12 months - Change in the cumulative postprandial response for insulin - Change in postprandial triglyceridemia - 3, 6, and 12 months - Change in the cumulative postprandial response for triglycerides 
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
